Neuroinflammation is common to various diseases of the central nervous system (CNS), but
its imprecise definition has led to many misconceptions in research and clinical approaches …

Neurological disorders are major contributors to death and disability worldwide. The
pathology of injuries and disease processes includes a cascade of events that often involve …

Background 'Encephalomyelitis disseminata'(multiple sclerosis) and myalgic
encephalomyelitis/chronic fatigue syndrome (ME/CFS) are both classified as diseases of the …

Multiple sclerosis (MS) is an immune-driven disease that affects the central nervous system
and is characterized by acute-on-chronic demyelination attacks. It is a major cause of global …

Objective Intravenous methylprednisolone is the standard treatment for a multiple sclerosis
relapse; however, this fails to improve symptoms in up to one quarter of patients …

Multiple sclerosis (MS) is a chronic autoimmune disorder characterized by inflammation,
demyelination, and neurodegeneration, resulting in significant disability and reduced quality …

Multiple sclerosis (MS) is a chronic, autoimmune condition that primarily affects the myelin
sheath covering the neurons of the central nervous system, including those of the brain and …

Immunoglobulin G (IgG) antibodies against myelin oligodendrocyte glycoprotein (MOG) are
detected in the serum of some patients with demyelinating diseases. These patients are …

Acute and subacute inflammation, the mechanisms by which demyelination and axonal loss
occur in multiple sclerosis (MS), result from the migration of activated immune cells into the …

Multiple sclerosis (MS) is a chronic, multifactorial disease of the central nervous system
(CNS), typified by repetitive relapses and/or progression. The conventional treatment …